AVITA Medical’s $69.1 Million Common Stock Offering

Davis Polk advised the joint book-running managers and representatives of the several underwriters in the offering.

AVITA Medical, Inc. executed its follow-on offering of 3,214,250 shares of common stock, including the full exercise by the underwriters of their option to purchase additional shares of common stock. The common stock is listed on the Nasdaq Stock Market LLC under the symbol “RCEL.”

Piper Sandler & Co. LLC, Cowen and Company, LLC, BTIG, LLC and Lake Street Capital Markets, LLC acted as underwriters for the offering.

Based in Valencia, California, AVITA Medical is a regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, chronic wounds and aesthetics indications. AVITA Medical’s proprietary collection and application technology provides innovative treatment solutions derived from the regenerative properties of a patient’s own skin.

The Davis Polk corporate team included partner Alan F. Denenberg (Picture) and associates Beth LeBow and Travis B. Mitchell. The tax team included partner Mario J. Verdolini and associate Shay Moyal. The intellectual property and technology transactions team included partner Frank J. Azzopardi and associate Mikaela Dealissia. Allison Gunther provided 1940 Act advice.

Involved fees earner: Frank Azzopardi – Davis Polk & Wardwell; Mikaela Dealissia – Davis Polk & Wardwell; Alan Denenberg – Davis Polk & Wardwell; Allison Gunther – Davis Polk & Wardwell; Beth LeBow – Davis Polk & Wardwell; Travis Mitchell – Davis Polk & Wardwell; Shay Moyal – Davis Polk & Wardwell; Mario Verdolini – Davis Polk & Wardwell;

Law Firms: Davis Polk & Wardwell;

Clients: BTIG, LLC; Cowen and Company; Lake Street Capital Markets LLC; Piper Sandler;

Author: Martina Bellini